YBX1

Y-box-binding protein 1 · P67809 · YBX1 on Sugi Atlas →

0 patent compounds predicted against YBX1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to YBX1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma PHASE1/PHASE2RECRUITING
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer PHASE2UNKNOWN
Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study PHASE2RECRUITING
SCARFREE-001: Verteporfin for Scar Prevention PHASE2NOT_YET_RECRUITING
Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer PHASE1RECRUITING
QH101 Cell Injection in Patients With Brain, Brain (Spinal) Meninges, and Spinal Cord Metastatic Malignant Solid Tumors EARLY_PHASE1NOT_YET_RECRUITING
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA) nanRECRUITING
Involvement of Pollutants in Atopic Dermatitis and Psoriasis nanUNKNOWN
Study of the Sex Differences in Inflammatory Diseases in Children nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients nanNOT_YET_RECRUITING
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Use of miRNAs in Growth Hormone Deficiency (GHD) nanUNKNOWN
Genetic Studies Spermatogenic Failure nanCOMPLETED
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea nanRECRUITING
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC) nanNOT_YET_RECRUITING
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage nanENROLLING_BY_INVITATION
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
Hippo-Related Competing Endogenous RNA (ceRNA) Network Dysregulation and In Vitro Fertilization (IVF) Outcomes in Women With Diminished Ovarian Reserve nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Implication of Long Non-coding RNA CCDC144NL-AS1/Micro RNA-143-3p Axis Expression Level as Novel Signature in Colorectal Cancer nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a YBX1 binder may also engage these)

ProteinNameSimilarity
P67808 1.000 P67808 →
P62961 1.000 P62961 →
Q06066 1.000 Q06066 →
Q28618 1.000 Q28618 →
P62960 1.000 P62960 →
Q00436 1.000 Q00436 →
P21573 1.000 P21573 →
Q62764 0.998 Q62764 →
B5DE31 0.995 B5DE31 →
P45441 0.995 P45441 →
P21574 0.994 P21574 →
Q9Z2C8 0.994 Q9Z2C8 →
YBX3 Y-box-binding protein 3 0.993 landscape →
Q9Y2T7 0.991 Q9Y2T7 →
Q9JKB3 0.989 Q9JKB3 →
P41824 0.982 P41824 →
Q9NFU0 0.981 Q9NFU0 →
P41073 0.981 P41073 →
Q9BLJ6 0.981 Q9BLJ6 →
Q21351 0.980 Q21351 →
Q09801 0.978 Q09801 →
Q4WM95 0.978 Q4WM95 →
Q9HGL3 0.977 Q9HGL3 →
Q9I9R0 0.977 Q9I9R0 →
P45978 0.977 P45978 →
A1L1K8 0.977 A1L1K8 →
Q6E3D4 0.976 Q6E3D4 →
Q10422 0.976 Q10422 →
Q6NYG6 0.976 Q6NYG6 →
Q5JVS0 0.976 Q5JVS0 →